Clinical Trial Update: The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluate the efficacy and tolerability of the NP101 patch for acute migraine treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• NP101 patch

Snippet

Sponsor: NuPathe Inc. | Conditions: Migraine Disorders | Phase 3 | Status: COMPLETED | Results posted: 2013-05-07